Global Cerebral Oximetry Monitoring Market

Cerebral Oximetry Monitoring Market Size, Share, Growth Analysis, By Age Group(Pediatric, and Adult), By End-use(Hospitals & Clinics, Ambulatory Surgical Centers, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2364 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 75

Cerebral Oximetry Monitoring Market Dynamics

Cerebral Oximetry Monitoring Market Drivers

Increasing Awareness of Patient Safety

  • Patient safety has emerged as a key driver in the cerebral oximetry monitoring market. Healthcare providers and regulatory bodies have placed a greater emphasis on improving patient outcomes and reducing the risk of adverse events during surgical procedures. Cerebral oximetry monitoring plays a crucial role in assessing and optimizing cerebral oxygenation, which is essential for patient safety during surgeries, particularly cardiac and vascular procedures. The growing awareness of the importance of patient safety has driven the adoption of cerebral oximetry monitoring devices.

Rising Incidence of Cardiovascular Diseases

  • The increasing prevalence of cardiovascular diseases (CVD) worldwide has acted as a driver for the cerebral oximetry monitoring market. CVDs, such as heart failure and coronary artery disease, often require surgical interventions that involve cardiac and cerebral perfusion management. Cerebral oximetry monitoring provides real-time information about cerebral oxygen saturation levels, aiding healthcare professionals in optimizing cerebral perfusion and reducing the risk of perioperative neurological complications. The rising incidence of CVDs has created a demand for cerebral oximetry monitoring devices in cardiac surgical settings.

Cerebral Oximetry Monitoring Market Restraints

High Cost of Cerebral Oximetry Monitoring Devices

  • One of the primary restraints in the cerebral oximetry monitoring market is the high cost associated with acquiring and maintaining monitoring devices. Cerebral oximeters utilize advanced technology and require specialized sensors and equipment, contributing to their higher price point. This cost factor can limit the affordability and accessibility of these devices, particularly in healthcare settings with budget constraints, hindering market growth.

Limited Reimbursement Coverage

  • Another restraint is the limited reimbursement coverage for cerebral oximetry monitoring procedures. Healthcare reimbursement policies and guidelines vary across different regions and countries, which can impact the adoption of cerebral oximetry monitoring devices. The lack of comprehensive reimbursement coverage or specific reimbursement codes can create barriers for healthcare providers, affecting their willingness to invest in and utilize these monitoring technologies.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cerebral Oximetry Monitoring Market size was valued at USD 202.65 Billion in 2022 and is poised to grow from USD 217.24 Billion in 2023 to USD 378.87 Billion by 2031, at a CAGR of 7.2% during the forecast period (2024-2031).

The global cerebral oximetry monitoring market is characterized by the presence of several key players striving to gain a competitive edge and capture a significant market share. These players engage in activities such as product development, strategic partnerships, and mergers and acquisitions to expand their product portfolios and strengthen their market position. Strategic partnerships and collaborations are another key aspect of the competitive landscape. Companies form alliances with healthcare institutions, research organizations, and other industry players to foster innovation, expand their customer base, and access new markets. For instance, Medtronic has collaborated with leading medical centers and academic institutions to conduct clinical studies and gather real-world data to validate the efficacy of their cerebral oximetry monitoring devices. 'Medtronic (US)', 'Edwards Lifesciences Corporation (US)', 'Masimo Corporation (US)', 'Nonin Medical (US)', 'Hamamatsu Photonics K.K. (Japan)', 'CAS Medical Systems (a subsidiary of Edwards Lifesciences) (USA)', 'Ornim Medical (Israel)', 'Natus Medical Incorporated (US)', 'Somanetics Corporation (US)', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)', 'GE Healthcare (US)', 'Hutchinson Technology Inc. (US)', 'Yokogawa Electric Corporation (Japan)', 'Nihon Kohden Corporation (Japan)', 'AdvanSource Biomaterials Corporation (US)', 'Hitachi Ltd. (Japan)', 'Philips Healthcare (Netherlands)', 'Spiegelberg GmbH & Co. KG (Germany)', 'ISS (International Stemcell Services Ltd.) (UK)', 'Perimed AB (Sweden)'

Patient safety has emerged as a key driver in the cerebral oximetry monitoring market. Healthcare providers and regulatory bodies have placed a greater emphasis on improving patient outcomes and reducing the risk of adverse events during surgical procedures. Cerebral oximetry monitoring plays a crucial role in assessing and optimizing cerebral oxygenation, which is essential for patient safety during surgeries, particularly cardiac and vascular procedures. The growing awareness of the importance of patient safety has driven the adoption of cerebral oximetry monitoring devices.

Technological Advancements in Monitoring Devices: A key trend in the cerebral oximetry monitoring market is the continuous advancement of monitoring devices. Manufacturers are investing in research and development to enhance the accuracy, functionality, and user-friendliness of cerebral oximeters. These advancements include features like wireless connectivity, improved data analysis capabilities, and integration with electronic health records, enabling seamless monitoring and data management. Technological innovations are aimed at providing healthcare professionals with more comprehensive and reliable information for optimal patient care.

In 2022, North America emerged as the dominant region in the cerebral oximetry monitoring market, capturing the largest revenue share of 37.41%. This can be attributed to the presence of key players and their offerings in the region. Major suppliers such as Medtronic, Edwards Lifesciences Corporation, Nonin, and Masimo provide oximeter devices like the INVOS System, ForeSight System, EQUINOX, and Root with O3 in the United States. These devices are utilized for monitoring cerebral desaturation in cardiac surgery, with applications in intensive care units (ICU), operating rooms (OR), and extracorporeal membrane oxygenation (ECMO). The availability of such advanced monitoring devices and the presence of established players contribute to the market's dominance in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cerebral Oximetry Monitoring Market

Report ID: SQMIG35A2364

$5,300
BUY NOW GET FREE SAMPLE